Prof. Lee Ann Applegate is the Director of the Cell Therapy Unit at the CHUV. She began her career with the study of the signaling pathways involved in cell and molecular skin repair and obtained her Ph.D. in science in 1987 at the University of New Mexico (Albuquerque). She then continued her postdoctorate at the Lovelace Medical Foundation (Albuquerque), and then at the MD Anderson Cancer Center at the University of Texas, in association with the Baylor College of Medicine, Houston. In 1989, thanks to the acquisition of an international research grant on cancer, she joined the Swiss Institute for Experimental Research on Cancer (ISREC) in Lausanne, Switzerland, where she devoted her research to the study of specific syndromes of skin cancers. In 1991, she joined the Dermatology Department of CHUV and continued her skin research. From 2000 to 2005, she worked in the Department of Gynecology-Obstetrics of the CHUV and oriented her experimental studies on the use of human progenitor cells in the mechanisms of healing and tissue repair. In 2005, she was appointed Director of the Cell Therapy Unit of CHUV. At the academic level and since 2003, she has been teaching at the UNIL Faculty of Biology and Medicine for doctors, as well as for biologists.
Prof. Lee Ann Applegate is the Director of the Cell Therapy Unit at the CHUV. She began her career with the study of the signaling pathways involved in cell and molecular skin repair and obtained her Ph.D. in science in 1987 at the University of New Mexico (Albuquerque). She then continued her postdoctorate at the Lovelace Medical Foundation (Albuquerque), and then at the MD Anderson Cancer Center at the University of Texas, in association with the Baylor College of Medicine, Houston. In 1989, thanks to the acquisition of an international research grant on cancer, she joined the Swiss Institute for Experimental Research on Cancer (ISREC) in Lausanne, Switzerland, where she devoted her research to the study of specific syndromes of skin cancers. In 1991, she joined the Dermatology Department of CHUV and continued her skin research. From 2000 to 2005, she worked in the Department of Gynecology-Obstetrics of the CHUV and oriented her experimental studies on the use of human progenitor cells in the mechanisms of healing and tissue repair. In 2005, she was appointed Director of the Cell Therapy Unit of CHUV. At the academic level and since 2003, she has been teaching at the UNIL Faculty of Biology and Medicine for doctors, as well as for biologists.